| # | Drug | Count |
|---|---|---|
| 0 | BUPRENORPHINE | 188 |
| 1 | PRASTERONE | 115 |
| 2 | ESTRADIOL | 85 |
| 3 | MECHLORETHAMINE HYDROCHLORIDE | 45 |
| 4 | MINOXIDIL | 42 |
| 5 | MINOXIDIL FOAM 5% (WOMENS) | 37 |
| 6 | ASPIRIN | 26 |
| 7 | ASPIRIN 325 MG | 25 |
| 8 | ASPIRIN 81 MG | 25 |
| 9 | NICOTINE | 23 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PRASTERONE | 115 | 0.0418 |
| 1 | SINECATECHINS | 2 | 0.0370 |
| 2 | MECHLORETHAMINE HYDROCHLORIDE | 45 | 0.0200 |
| 3 | TRAVOPROST INTRACAMERAL | 2 | 0.0169 |
| 4 | AVOBENZONE, HOMOSALATE, OCTISALAT, OCTOCRYLENE | 2 | 0.0142 |
| 5 | AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE | 2 | 0.0134 |
| 6 | BACITRACIN ZINC, NEOMYCIN SULFATE, AND POLYMYXIN B SULFATE | 1 | 0.0122 |
| 7 | BACITRACIN, NEOMYCIN, POLYMYXIN B, PRAMOXINE HCL | 1 | 0.0109 |
| 8 | BERDAZIMER | 1 | 0.0105 |
| 9 | CLOBETASOL PROPIONATE CREAM USP, 0.05% | 1 | 0.0101 |
| # | Drug class | Count |
|---|---|---|
| 0 | Partial Opioid Agonist [EPC] | 188 |
| 1 | Estrogen [EPC] | 95 |
| 2 | Alkylating Drug [EPC] | 47 |
| 3 | Arteriolar Vasodilator [EPC] | 47 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 46 |
| 5 | 5-alpha Reductase Inhibitor [EPC] | 41 |
| 6 | Cholinergic Nicotinic Agonist [EPC] | 29 |
| 7 | Corticosteroid [EPC] | 26 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 26 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 23 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Partial Opioid Agonist [EPC] | 188 | 0.0020 |
| 1 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 2 | Benzodiazepine Antagonist [EPC] | 1 | 0.0011 |
| 3 | Monoamine Oxidase Inhibitor [EPC] | 2 | 0.0006 |
| 4 | Arteriolar Vasodilator [EPC] | 47 | 0.0006 |
| 5 | Pyrethroid [EPC] | 1 | 0.0006 |
| 6 | Estrogen [EPC] | 95 | 0.0005 |
| 7 | Cholinergic Nicotinic Agonist [EPC] | 29 | 0.0005 |
| 8 | 5-alpha Reductase Inhibitor [EPC] | 41 | 0.0004 |
| 9 | Estrogen Agonist/Antagonist [EPC] | 1 | 0.0004 |